Industry News

Altair Nanotechnologies Is Selected as a Component of Global Crown Capital's New Nanotechnology Index

Published on 2006-01-03. Author : SpecialChem

RENO, NV -- Altair Nanotechnologies Inc. (NasdaqSC:ALTI - News), announced that it has been selected for inclusion in a new nanotechnology index launched by San Francisco-based Global Crown Capital. The new index, The Global Crown Capital Nanotechnology Index (TM), is a price-weighted index currently composed of nineteen pure play nanotechnology stocks that represent the emerging nanotechnology industry.

"The Global Crown Capital Nanotechnology index is innovative and unique to other indexes covering nanotechnology," commented Altairnano's CEO, Alan J. Gotcher Ph.D. "The components in this index must have a significant share of their total revenue generated from involvement in the research, development and manufacturing of nanomaterials and nano-devices covering a broad spectrum of industries. This eliminates large Fortune companies and allows investors to focus on pure nanotech companies. Altair's hard work and commitment to its R&D efforts, product development, and manufacturing of nanomaterials is becoming recognized by the investing community," added Gotcher.

In addition to Altair's inclusion in The Global Crown Capital Nanotechnology Index, Altair is a component of the Punk Ziegel Nanotech Index, the Merrill Lynch Nanotech Index, the Lux Nanotech Index(TM) and the Innovest Strategic Value Advisors Nanotech Index. Altair's common stock, symbol ALTI, is also a component of the PowerShares Lux Nanotech ETF (exchange traded fund), symbol (AMEX:PXN - News), which trades on the American Stock Exchange.

About Altair Nanotechnolgies Inc.

Altairnano is a leading supplier and innovator of advanced ceramic nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a unique team of materials scientists who, coupled in collaborative ventures with industry partners and leading academic centers, have pioneered an array of intellectual property and products.

Altairnano's robust proprietary technology platforms produce a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has scalable manufacturing capability to meet emerging nanomaterials demands. Altairnano's two divisions, Life Sciences and Performance Materials, are focused on applications where its nanotechnology may enable new high growth markets. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials and other medical markets. The Performance Materials Division is focused on market applications in advanced materials for paints and coatings; air and water treatment and alternative energy, including new lithium ion battery electrode materials.

Source: Altair Nanotechnologies Inc.

Sustainnovation is not a buzzword
Channel Alerts

Receive weekly digests on hot topics

Back to Top